NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
about
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndromeAdvances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopHow I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulationSomatic mutagenesis in autoimmunityOncogenic Kras initiates leukemia in hematopoietic stem cellsA restricted spectrum of NRAS mutations causes Noonan syndromeJMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entitiesFAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndromeCo-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndromeDominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbControl of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).ALPS-ten lessons from an international workshop on a genetic disease of apoptosisSomatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.The power and the promise of restimulation-induced cell death in human immune diseases.Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisRas in cancer and developmental diseasesNew advances in the diagnosis and treatment of autoimmune lymphoproliferative syndromeRole of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation.Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.Clues to immune tolerance: the monogenic autoimmune syndromesBcl-2-regulated cell death signalling in the prevention of autoimmunity.A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations.NF-kappaB-mediated modulation of inducible nitric oxide synthase activity controls induction of the Epstein-Barr virus productive cycle by transforming growth factor beta 1IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndromeThe expanding spectrum of the autoimmune lymphoproliferative syndromesManagement of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.Bim and Bmf in tissue homeostasis and malignant disease.K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.Human genetic approaches to diseases of lymphocyte activation.Tipifarnib-mediated suppression of T-bet-dependent signaling pathways.Constitutively active STAT6 predisposes toward a lymphoproliferative disorderCleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis.Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.Critical role for BIM in T cell receptor restimulation-induced deathGenetic defects of apoptosis and primary immunodeficiency.A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.
P2860
Q24623046-5A66BF19-89DF-438A-8918-FC781647C0E8Q24623371-C13FDE9A-0337-4CF8-B98D-7914488C9629Q24632569-B7FAE796-EACB-4CE0-89C3-ABF215FD0DEDQ24633207-073871A1-FE7A-47D5-8680-D1C5930FB692Q24643047-86AEE476-754D-4C5F-A1F8-669408287987Q24655603-C2D828F4-38CF-4BEA-97EB-ECB6FBC38755Q26860815-2122A6E9-6402-4B5E-81F7-304B0983064AQ27331698-500B2C0B-E7CD-43E3-8EA7-79F16AF90B5AQ27658480-FD8510D1-B736-4A6C-9937-764EF1C90BF8Q28082598-7E9BB549-850E-4479-B2FA-47C33CDD451BQ28235519-D2499AF7-58DA-49F8-A85F-68900CBFC552Q30838565-52B690B0-CF2D-4999-B67B-149E8E4455E5Q33289658-C4255D5B-0EC8-4C7C-812C-535390282D1BQ33413641-6B730727-9749-4520-9180-5DF49B2BFA14Q33420245-1072C29D-A250-4A1F-B633-4ABB8541BCFFQ33807422-FEC94F6F-FB7B-4587-A853-A63F1FA619C4Q33944255-2932DF6C-DE5B-4C96-979E-005454D7CAC7Q34009654-9AC25E53-0BFD-47FD-BD12-B62B6F75BED4Q34149957-D2FA8D5E-D121-473A-9062-DDBCA0E696C7Q34202697-89A7CCA0-5B31-44BF-9390-44337D4DF0A0Q34239719-FA324932-B111-4453-A240-0B85AB4B0C2CQ34255132-A1EC6B5C-B2FF-4FB1-A4D8-9427226F9323Q34375180-D7A4B676-E220-4962-8126-934CF7D8958BQ34440616-F9C5893F-A05C-4332-A35E-2F3922FC7FCCQ34545377-D8BA90DD-C8DA-49BC-9EAE-300986D62CA2Q34789915-8EC1C2EA-D636-4E69-86E8-20CA7C35F9C1Q35077613-E8A70BBC-E14B-4DEA-BE00-4D57F3285D81Q35130847-3C110A5D-40DF-48EA-8639-31648F6E39EDQ35619447-45CA3580-A613-441E-8310-04252E3FD6D5Q35672286-560DD84E-2054-43B5-ABB1-B7A4D2E555A7Q35737865-A3DF2991-2D4B-4556-8E58-0A817099835FQ36056599-40E7D458-3C06-4B4F-B166-669A33145FC5Q36152005-91FCA51E-76F7-4DB1-8FB0-F50A33943EC6Q36181770-9310E733-BC88-4BBC-AB5A-A252C2528B5DQ36447909-2F389FC5-2A14-44CE-8B9C-FBA04D30736AQ36487244-23217E28-0889-4732-AA5D-75CA4B22434CQ36708937-865265FE-E1ED-4C4A-B690-80D96D5C58A1Q36862396-59493766-17B0-4222-B099-5353AAA83CEAQ37142878-67FC7DD9-2B2A-494B-868C-AEB7475B2AF1Q37151172-F9D61BFD-C863-4997-A2AB-C9B9C37ED4B3
P2860
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@ast
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@en
type
label
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@ast
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@en
prefLabel
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@ast
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
@en
P2093
P2860
P356
P1476
NRAS mutation causes a human autoimmune lymphoproliferative syndrome
@en
P2093
Cynthia P Nix
Janet Dale
Jennifer Barb
Jennifer M Puck
Keiko Sakai
Lixin Zheng
Michael J Lenardo
Nicolas Bidère
Peter J Munson
Robert L Danner
P2860
P304
P356
10.1073/PNAS.0702975104
P407
P577
2007-05-16T00:00:00Z